Northern Trust Corp Bio Techne Corp Transaction History

Northern Trust Corp

$572 Billion
Q1 2024

A detailed history of Northern Trust Corp transactions in Bio Techne Corp stock. As of the latest transaction made, Northern Trust Corp holds 1,534,302 shares of TECH stock, worth $118 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,534,302

Previous 1,597,543 3.96%

Holding current value

$118 Million

Previous $123 Million 12.39%

% of portfolio

0.02%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$65.98 - $77.09 $4.17 Million - $4.88 Million	-63,241 Reduced 3.96%	1,534,302 $108 Million
Q4 2023 Feb 13, 2024	SELL	$52.83 - $78.22 $1.56 Million - $2.31 Million	-29,530 Reduced 1.81%	1,597,543 $123 Million
Q3 2023 Nov 13, 2023	BUY	$67.52 - $89.42 $2.58 Million - $3.42 Million	38,223 Added 2.41%	1,627,073 $111 Million
Q2 2023 Aug 11, 2023	SELL	$73.76 - $85.98 $1.39 Million - $1.62 Million	-18,871 Reduced 1.17%	1,588,850 $130 Million
Q1 2023 May 15, 2023	SELL	$71.62 - $86.62 $3.13 Million - $3.79 Million	-43,747 Reduced 2.65%	1,607,721 $119 Million

Q4 2022 Feb 13, 2023	BUY	$80.67 - $352.29 $101 Million - $441 Million	1,251,103 Added 312.49%	1,651,468 $137 Million
Q3 2022 Nov 14, 2022	SELL	$282.54 - $391.85 $3.83 Million - $5.31 Million	-13,553 Reduced 3.27%	400,365 $114 Million
Q2 2022 Aug 12, 2022	SELL	$322.67 - $449.65 $8.85 Million - $12.3 Million	-27,421 Reduced 6.21%	413,918 $143 Million
Q1 2022 May 13, 2022	SELL	$353.85 - $487.79 $998,564 - $1.38 Million	-2,822 Reduced 0.64%	441,339 $191 Million
Q4 2021 Feb 08, 2022	SELL	$456.15 - $525.06 $1.73 Million - $1.99 Million	-3,795 Reduced 0.85%	444,161 $230 Million
Q3 2021 Nov 15, 2021	BUY	$444.87 - $538.88 $11.4 Million - $13.8 Million	25,520 Added 6.04%	447,956 $217 Million
Q2 2021 Aug 13, 2021	BUY	$387.35 - $450.26 $21.6 Million - $25.1 Million	55,752 Added 15.2%	422,436 $190 Million
Q1 2021 May 12, 2021	BUY	$314.62 - $411.0 $3.82 Million - $4.99 Million	12,144 Added 3.43%	366,684 $140 Million
Q4 2020 Feb 11, 2021	BUY	$246.9 - $321.87 $156,781 - $204,387	635 Added 0.18%	354,540 $113 Million
Q3 2020 Nov 16, 2020	SELL	$232.22 - $282.96 $2.03 Million - $2.47 Million	-8,736 Reduced 2.41%	353,905 $87.7 Million
Q2 2020 Aug 14, 2020	BUY	$185.43 - $279.56 $3.15 Million - $4.75 Million	16,979 Added 4.91%	362,641 $95.8 Million
Q1 2020 May 14, 2020	BUY	$161.17 - $221.51 $1.78 Million - $2.44 Million	11,032 Added 3.3%	345,662 $65.5 Million
Q4 2019 Feb 14, 2020	BUY	$189.68 - $222.09 $1.34 Million - $1.57 Million	7,088 Added 2.16%	334,630 $73.5 Million
Q3 2019 Nov 13, 2019	SELL	$183.56 - $216.72 $801,055 - $945,766	-4,364 Reduced 1.31%	327,542 $64.1 Million
Q2 2019 Aug 13, 2019	SELL	$188.72 - $215.43 $815,459 - $930,873	-4,321 Reduced 1.29%	331,906 $69.2 Million
Q1 2019 May 13, 2019	BUY	$136.09 - $200.44 $1.09 Million - $1.6 Million	7,986 Added 2.43%	336,227 $66.8 Million
Q4 2018 Feb 12, 2019	SELL	$132.75 - $203.8 $3.2 Million - $4.92 Million	-24,117 Reduced 6.84%	328,241 $47.5 Million
Q3 2018 Nov 14, 2018	SELL	$147.44 - $204.11 $2.77 Million - $3.84 Million	-18,804 Reduced 5.07%	352,358 $71.9 Million
Q2 2018 Sep 18, 2018	SELL	$144.9 - $165.58 $349,643 - $399,544	-2,413 Reduced 0.65%	371,162 $54.9 Million
Q2 2018 Aug 14, 2018	SELL	$144.9 - $165.58 $847,230 - $968,146	-5,847 Reduced 1.54%	373,575 $55.3 Million
Q1 2018 May 09, 2018	SELL	$131.46 - $151.04 $54,030 - $62,077	-411 Reduced 0.11%	379,422 $57.3 Million
Q4 2017 Feb 14, 2018	SELL	$121.17 - $134.75 $5.73 Million - $6.37 Million	-47,264 Reduced 11.07%	379,833 $49.2 Million
Q3 2017 Nov 13, 2017	BUY	$113.59 - $123.78 $48.5 Million - $52.9 Million	427,097	427,097 $51.6 Million

Others Institutions Holding TECH

# of Institutions

581

Shares Held

154M

Call Options Held

180K

Put Options Held

189K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $3.03B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Bio Techne Corp Transaction History